Australian Army and QinetiQ MakerSpace program expands - Asia Pacific Defence Reporter
| FBIOX Fund | USD 20.42 0.21 1.02% |
Slightly above 61% of Biotechnology Portfolio's investor base is looking to short. The analysis of overall sentiment of trading Biotechnology Portfolio Biotechnology mutual fund suggests that many investors are alarmed at this time. Biotechnology Portfolio's investing sentiment can be driven by a variety of factors including economic data, Biotechnology Portfolio's earnings reports, geopolitical events, and overall market trends.
Biotechnology |
Australian Army and QinetiQ MakerSpace program expands Asia Pacific Defence Reporter
Read at news.google.com
 |
Biotechnology Portfolio Fundamental Analysis
We analyze Biotechnology Portfolio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Three Year Return
Three Year Return Comparative Analysis
Biotechnology Portfolio is currently under evaluation in three year return among similar funds. Tree Year Return shows the total annualized return generated from holding a fund or ETFs for the last three years. The return measure includes capital appreciation, losses, dividends paid, and all capital gains distributions. This return indicator is considered by many investors to be solid measures of fund mid-term performance.
Biotechnology Portfolio Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biotechnology Portfolio mutual fund to make a market-neutral strategy. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics with similar companies.
Peers
Biotechnology Portfolio Related Equities
| FQLSX | Fidelity Flex | 0.07 |
| ||
| FRAMX | Fidelity Income | 0.14 |
| ||
| FPTKX | Fidelity Freedom | 0.17 |
| ||
| FPXTX | Fidelity Pennsylvania | 0.28 |
| ||
| FPUKX | Fidelity Puritan | 0.51 |
| ||
| FRAGX | Aggressive Growth | 0.51 |
| ||
| FPURX | Fidelity Puritan | 0.51 |
| ||
| FQIPX | Fidelity Freedom | 0.52 |
| ||
| FQIFX | Fidelity Freedom | 0.66 |
| ||
| FQITX | Fidelity Salem | 0.79 |
|
Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |